The hypotensive effect of topical prostaglandin application with respect to involutional changes of the anterior portion of the uveal tract
https://doi.org/10.21516/2072-0076-2016-9-2-38-41
Abstract
The hypotensive effect of xalatan was analyzed in patients with primary open-angle glaucoma (POAG). This effect was evaluated with respect to involutional changes of the anterior portion of the uveal tract. We examined 50 patients with POAG and dystrophic changes in the iris, namely those newly diagnosed with the disease, those with bilateral process and those who received no hypotensive treatment before. The degree of the glaucomatous process was shown to have the most impact on the development of dystrophic changes in the iris. The visual field changes followed for 6 months turned out to be insignificant. No clear data confirming the dependence of the hypotensive effect of xalatan instillations on the magnitude of dystrophic changes in the iris were revealed // Russian Ophthalmological Journal, 2016; 2: 38-41 . doi: 10.21516/2072-0076-2016-9-2-38-41 .
About the Authors
O. A. Koroev
North-Ossetian State Medical Academy Vladikavkaz, Russia
Russian Federation
Russian Federation
E. V. Khadikova
North-Ossetian State Medical Academy Vladikavkaz, Russia
Russian Federation
Russian Federation
A. O. Koroev
North-Ossetian State Medical Academy Vladikavkaz, Russia
Russian Federation
Russian Federation
M. A. Sozaeva
North-Ossetian State Medical Academy Vladikavkaz, Russia
Russian Federation
Russian Federation
I. V. Kaloeva
North-Ossetian State Medical Academy Vladikavkaz, Russia
Russian Federation
Russian Federation
References
1. Басинский С.Н., Баранов В.И., Цветков А.Н. Влияние однократной инстилляции латанопроста на уровень внутриглазного давления у больных с нестабилизированной первичной глаукомой. Клиническая офтальмология. 2005; 6(3): 132-3.
2. Ермакова В.Н. Эффективность, переносимость и механизм гипотензивного действия ксалатана (латанопроста) при первичной глаукоме. Глаукома. 2006; 1:14-9.
3. Bayer A., Hendere R.J. Clinical predictors of latanoprost treatment effect. J. Glaucoma. 2005; 14(4): 260-2.
4. TakahashI I., Tanaka M. Switching to latanoprost monotherapy for 24 weeks in glaucoma patients. Eur. J. Ophthalmol. 2004; 14: 401-6.
5. Короев O.A., Хадикова Э.В., Kopoeв A.O. и др. Дистрофические изменения радужной оболочки у больных первичной открытоугольной глаукомой. Международный научно- исследовательский журнал. 2013; 11(3-4): 52-5.
6. Пучковская Н.А., ред. Офтальмогериатрия. Москва: Медицина; 1982. Puchkovskaya N.A., ed. Ophthalmogeriatry. Moscow: Meditsina; 1982. (In Russian).
7. Симаков И.М., Бойко Э.B. Анализ эффективности ксалатана в лечении первичной открытоугольной глаукомы. Глаукома. 2007; 3: 23-7.
8. Bernstein Р. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator, muiticenter study. Am. J. Ophthalmol. 2004; 137: 387-8.
9. Noecker R. S., Dirks M. S., Choplin N. Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator muiticenter study. Am. J. Ophthalmol. 2004; 137: 210-1.
Review
For citations:
Koroev O.A., Khadikova E.V., Koroev A.O., Sozaeva M.A., Kaloeva I.V. The hypotensive effect of topical prostaglandin application with respect to involutional changes of the anterior portion of the uveal tract. Russian Ophthalmological Journal. 2016;9(2):38-41. (In Russ.) https://doi.org/10.21516/2072-0076-2016-9-2-38-41
Views:
570
Email this article 